Efficacy of mepolizumab for the treatment of eosinophilic cystitis: a report of two cases

J Investig Allergol Clin Immunol. 2023 Oct 17:0. doi: 10.18176/jiaci.0954. Online ahead of print.

L Trefond^{1

2}, L Guy³, C Darcha⁴, A Gallon⁵, R Thomas-Monier⁵, K Berdugo⁶, P Smets¹, L Olagne¹, J Stievenart¹, D Fayard¹, P Cathebras⁶, O Aumaitre^{1

2}, L Boyer⁵, M Andre^{1

2}, J E Kahn⁷

¹ Service de Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
² Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 1382, 63000 Clermont-Ferrand, France.
³ Service d'Urologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
⁴ Service d'Anatomopathologie, CHU Estaing, Clermont Ferrand, France.
⁵ Service de Radiologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
⁶ Service de Médecine Interne, CHU de Saint-Étienne, France.
⁷ National Reference Center for Hypereosinophilic Syndromes, CEREO, France; Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, F-92100 Boulogne-Billancourt, France.

No abstract available

Keywords: Eosinophilic cystitis; Hypereosinophilic syndrome; Mepolizumab.